AccessTLC is a multifaceted, multi-partner initiative sponsored by the University of Wisconsin School of Medicine and Public Health in partnership with the National Lung Cancer Partnership and its chapter, North Carolina Lung Cancer Partnership, and Healthcare Performance Consulting. Using national experts, AccessTLC has developed a free, online Learning from Self-Assessment (LSA) CME activity* that can be accessed at http://cme.wisc.edu/LSA/AccessTLC/index.php. This activity has been approved for AMA PRA Category 1 CreditTM.
The goals of AccessTLC are to: reduce the delay in diagnosis and treatment of lung cancer in the US thereby limiting disease progression prior to treatment, increase access to stage-appropriate care based on the scientific evidence, and increase the number of lung cancer patients who are enrolled in clinical trials thus shortening the time required to make new and more effective treatments available to patients. Click here to learn more about Access TLC.
*The University of Wisconsin School of Medicine and Public Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This activity is supported by an educational grant from Pfizer.
